Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy

Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mike, Jana Krystofova, White, Yasmine, Hutchings, Rachel S., Vento, Christian, Ha, Janica, Iranmahboub, Ariana, Manzoor, Hadiya, Gunewardena, Anya, Cheah, Cheryl, Wang, Aijun, Goudy, Brian D., Lakshminrusimha, Satyan, Long-Boyle, Janel, Fineman, Jeffrey R., Ferriero, Donna M., Maltepe, Emin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670092/
https://www.ncbi.nlm.nih.gov/pubmed/38002819
http://dx.doi.org/10.3390/children10111728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670092/
https://www.ncbi.nlm.nih.gov/pubmed/38002819
http://dx.doi.org/10.3390/children10111728

Ejemplares similares